Your browser doesn't support javascript.
loading
Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada.
Lachance, Sylvie; Gomes, Marcio M; Bambace, Nadia M; Bittencourt, Henrique; Lepic, Kylie; Shafey, Mona; Karpinski, Jolanta; Guilcher, Gregory M T.
Afiliación
  • Lachance S; Institut Universitaire d'Hémato-oncologie et Thérapie Cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada. Electronic address: silvy.lachance@umontreal.ca.
  • Gomes MM; Specialties Unit, Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Bambace NM; Institut Universitaire d'Hémato-oncologie et Thérapie Cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada; Department of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Bittencourt H; Cell Therapy Program, Hematology-Oncology Division, CHU Sainte-Justine, Montreal, Quebec, Canada; Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada.
  • Lepic K; Cellular Therapy and Transplant Program, Division of Hematology and Thromboembolism, Juravinski Hospital and Cancer Centre, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Shafey M; Specialties Unit, Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada; Hematopoietic Cell Transplant Program, Tom Baker Cancer Centre, Calgary, Alberta, Canada; Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Karpinski J; Specialties Unit, Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada.
  • Guilcher GMT; Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada; Section of Pediatric Oncology/BMT, Departments of Oncology and Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Transplant Cell Ther ; 27(9): 702-706, 2021 09.
Article en En | MEDLINE | ID: mdl-34153503
ABSTRACT
Hematopoietic stem cell transplantation (HSCT) and cellular therapy (CT) exploit the therapeutic potential of manipulated or unmanipulated hematopoietic cells to treat diseases. While initially dedicated to the treatment of hematologic malignancies and disorders, the use of these therapies in several diseases and cancers is currently under investigation. Indications are currently booming. In the midst of this expansion, both the American Society for Transplantation and Cellular Therapy (ASTCT) and the European Society for Blood and Marrow Transplantation (EBMT) have highlighted the global shortage of hematologists adequately trained in this field of high expertise. This shortage in transplant physicians and cellular therapists can significantly impact patients' access to cell-based therapy. To address this unmet need and attract aspiring hematologists to the field of cellular therapy, as well as to standardize training, anticipating this trend, a Canadian national task force aiming to develop a structured academic program in HSCT and CT was created. Workshops were organized to identify and establish the fundamentals of the practice in HSCT and CT. These workshops followed a rigorous process in developing the competency-based training program established by the Royal College. The program begins with the development of the main tasks associated with the practice of the discipline and the evidence that trainees must provide to demonstrate that they can perform these tasks independently (the competence portfolio). It continues with the development of training requirements that summarize the knowledge, skills, and aptitudes required to perform these tasks, followed by specific exposure during training (milestones) essential to demonstrate the acquisition of these skills. HSCT and CT together is now formally recognized as an Area of Focused Competence (AFC) by the Royal College of Physicians and Surgeons of Canada, a national organization that provides oversight of the medical education of specialists in Canada. AFCs are areas of specialty medicine that address a legitimate societal and patient population need previously unmet by the system of primary and subspecialty disciplines. The AFC designation for HSCT and CT provides a standardized curriculum, training experience, and accreditation process to attract young hematologists and promote expertise and quality care to meet the needs of both patients and society. A critical number of highly qualified hematologists will ensure continuing expansion of accessibility to HSCT and CT.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Educación Médica Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Educación Médica Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article